Literature DB >> 2887840

Induction of puberty by pulsatile gonadotropin releasing hormone.

R Stanhope, C G Brook, P J Pringle, J Adams, H S Jacobs.   

Abstract

15 girls and 17 boys with delayed or arrested puberty were treated with gonadotropin releasing hormone (GnRH) for a mean of 1.04 years. GnRH was administered subcutaneously in a pulsatile fashion at 90 min intervals, and the dose was increased as required to maintain progression of puberty, initially only at night and subsequently over 24 h. Initial GnRH dose was 1-2 micrograms per pulse in the girls and 2-4 micrograms per pulse in the boys. The effect of treatment was monitored by serial overnight gonadotropin profiles in all patients and with pelvic ultrasound in the girls. The clinical features, growth acceleration, endocrinology, and ovarian ultrasound morphology of puberty were those seen in normal children. Measurement of spontaneous gonadotropin pulsatility after treatment had been discontinued allowed the distinction between 20 patients with hypogonadotropic hypogonadism and 12 who had constitutional delay of growth and puberty. 2 girls and 6 boys did not respond to the treatment regimen. These findings indicate that normal puberty is GnRH dependent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887840     DOI: 10.1016/s0140-6736(87)92932-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Delayed puberty.

Authors:  R Stanhope; A Albanese; S Shalet
Journal:  BMJ       Date:  1992-10-03

2.  Injection sites and pharmacokinetics of luteinizing hormone releasing hormone: comparison of two different subcutaneous administration routes.

Authors:  R Torre; L Traverso; P Cavagnaro; M Giusti; G Giordano
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

Review 3.  Update on pulsatile luteinizing hormone-releasing hormone therapy in males with idiopathic hypogonadotropic hypogonadism and delayed puberty.

Authors:  M Giusti; P Cavagnaro
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

Review 4.  Management of constitutional delay of growth and puberty.

Authors:  R Stanhope; M A Preece
Journal:  Arch Dis Child       Date:  1988-09       Impact factor: 3.791

Review 5.  Maturation of sleep-wake gonadotrophin-releasing hormone secretion across puberty in girls: potential mechanisms and relevance to the pathogenesis of polycystic ovary syndrome.

Authors:  C R McCartney
Journal:  J Neuroendocrinol       Date:  2010-05-12       Impact factor: 3.627

6.  Does constitutional delayed puberty cause segmental disproportion and short stature?

Authors:  A Albanese; R Stanhope
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

7.  Sexual precocity: sex incidence and aetiology.

Authors:  N A Bridges; J A Christopher; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

Review 8.  Growth hormone deficiency throughout puberty.

Authors:  A Albanese; R Stanhope
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

9.  The relationship between Insulin-like Growth Factor 1, sex steroids and timing of the pubertal growth spurt.

Authors:  T J Cole; M L Ahmed; M A Preece; P Hindmarsh; D B Dunger
Journal:  Clin Endocrinol (Oxf)       Date:  2015-01-08       Impact factor: 3.478

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.